Light dynamics for cancer treatment

May 3, 2012

Research is delving into refinement of a revolutionary cancer treatment, photodynamic therapy (PDT). Using light, reactive oxygen and photosensitisers linked to specially designed antibodies, scientists are on the threshold of a highly specific cancer therapy.

PDT is an ingenious treatment using a drug – a photosensitiser – that absorbs light of a certain wavelength thereby inducing production of reactive that in turn kills nearby cells. Specially designed photosensitisers are absorbed by all cells in the body but stay in cells longer. This means that reactive oxygen destroys cancer cells selectively when they are exposed to the appropriate light wavelength.

The therapy is suitable for the removal of superficial neoplastic tumours in areas like the head and neck as well as urogenital and gynaecological systems that are inoperable. As the wavelength of the light determines how far the light travels into the body, the technique in principle has huge potential in that only destroys tumour and not healthy cells.

An EU-funded project 'Immunophotodynamic therapy of cancer: concepts and applications' (Immuno PDT) aimed to further improve the efficacy of PDT by developing novel photosensitisers that absorb light in the infrared range where light penetration of tissues is maximal. Furthermore, the Immuno PDT team targeted tumour neo-vasculature to close tumour blood vessels thereby destroying many tumour cells dependent on blood supply.

Immuno PDT made substantial progress in the development of antibody-based photosensitiser conjugates made up of the photosensitiser bound to an antibody. The researchers synthesised photosensitive molecules that do not stick to unwanted cells and tissues. Novel human antibodies were also isolated for corresponding tumour- associated antigens.

Dependent on the antibody and photosensitiser efficiently joining together, Immuno PDT successfully investigated a new method of conjugation. Novel PDT agents have been extensively tested in vitro and in rat models. At close of the project, three of the new were being manufactured for potential clinical use and eight patent applications had been submitted.

Apart from the applications in therapy for otherwise inoperable tumours, there is considerable scope for other treatments under the umbrella of immunotherapy. These include biological treatments for cancers using the body's immune system to fight tumours.

Explore further: Light, chemistry, action -- a new technique to target skin cancers?

Related Stories

Light, chemistry, action -- a new technique to target skin cancers?

April 11, 2011
Targeted photodynamic therapy can completely eradicate some models of cancer, according to the latest research by UK and Swiss scientists, published in the current issue of the British Journal of Cancer.

Recommended for you

Cancer-death button gets jammed by gut bacterium

July 27, 2017
Researchers at Michigan Medicine and in China showed that a type of bacterium is associated with the recurrence of colorectal cancer and poor outcomes. They found that Fusobacterium nucleatum in the gut can stop chemotherapy ...

Researchers release first draft of a genome-wide cancer 'dependency map'

July 27, 2017
In one of the largest efforts to build a comprehensive catalog of genetic vulnerabilities in cancer, researchers from the Broad Institute of MIT and Harvard and Dana-Farber Cancer Institute have identified more than 760 genes ...

Long-sought mechanism of metastasis is discovered in pancreatic cancer

July 27, 2017
Cells, just like people, have memories. They retain molecular markers that at the beginning of their existence helped guide their development. Cells that become cancerous may be making use of these early memories to power ...

Blocking the back-door that cancer cells use to escape death by radiotherapy

July 27, 2017
A natural healing mechanism of the body may be reducing the efficiency of radiotherapy in breast cancer patients, according to a new study.

Manmade peptides reduce breast cancer's spread

July 27, 2017
Manmade peptides that directly disrupt the inner workings of a gene known to support cancer's spread significantly reduce metastasis in a mouse model of breast cancer, scientists say.

Glowing tumor technology helps surgeons remove hidden cancer cells

July 27, 2017
Surgeons were able to identify and remove a greater number of cancerous nodules from lung cancer patients when combining intraoperative molecular imaging (IMI) - through the use of a contrast agent that makes tumor cells ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.